{
      "brief_title": [
            "phase",
            "ii",
            "study",
            "patient",
            "recurrent",
            "lung",
            "cancer"
      ],
      "brief_summary": [
            "determine",
            "tumor",
            "response",
            "rate",
            "time",
            "disease",
            "progression",
            "survival",
            "safety",
            "total",
            "population"
      ],
      "detailed_description": [
            "determine",
            "tumor",
            "response",
            "rate",
            "time",
            "disease",
            "progression",
            "survival",
            "safety",
            "total",
            "population"
      ],
      "condition": [
            "lung",
            "cancer"
      ],
      "intervention_type": [
            "biological"
      ],
      "intervention_name": [
            "cetuximab"
      ],
      "description": [
            "cetuximab",
            "400",
            "intravenously",
            "iv",
            "120",
            "minute",
            "day",
            "1",
            "cycle",
            "follow",
            "weekly",
            "dose",
            "250",
            "60",
            "minute"
      ],
      "arm_group_label": [
            "1"
      ],
      "other_name": [
            "erbitux"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "1",
            "subject",
            "recurrent",
            "progressive",
            "nsclc",
            "either",
            "present",
            "prior",
            "histologic",
            "confirmation",
            "pathologic",
            "confirmation",
            "nsclc",
            "2",
            "subject",
            "receive",
            "1",
            "prior",
            "chemotherapy",
            "regimen",
            "treatment",
            "disease",
            "include",
            "least",
            "1",
            "combination",
            "3",
            "unidimensionally",
            "measurable",
            "nsclc",
            "4",
            "subject",
            "tumor",
            "tissue",
            "available",
            "egfr",
            "assessment",
            "5",
            "ecog",
            "performance",
            "status",
            "0",
            "1",
            "6",
            "subject",
            "asymptomatic",
            "brain",
            "metastasis",
            "eligible",
            "however",
            "must",
            "complete",
            "least",
            "3",
            "week",
            "prior",
            "enrollment",
            "steroid",
            "exclusion",
            "criterion",
            "1",
            "woman",
            "childbearing",
            "potential",
            "unwilling",
            "unable",
            "use",
            "acceptable",
            "method",
            "avoid",
            "pregnancy",
            "entire",
            "study",
            "period",
            "4",
            "week",
            "study",
            "male",
            "subject",
            "must",
            "also",
            "agree",
            "use",
            "effective",
            "contraception",
            "2",
            "woman",
            "childbearing",
            "potential",
            "use",
            "prohibit",
            "contraceptive",
            "method",
            "3",
            "woman",
            "pregnant",
            "breastfeed",
            "4",
            "woman",
            "positive",
            "pregnancy",
            "test",
            "enrollment",
            "prior",
            "study",
            "drug",
            "administration"
      ],
      "gender": [],
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": false,
      "id": "NCT00063388.xml"
}